The bill establishes new regulations regarding cost-sharing requirements for insulin and diabetes supplies under Florida law by creating a new section, 627.42398, in the Florida Statutes. It defines "cost-sharing requirement" to include an insured's deductible, coinsurance, copayment, or similar out-of-pocket expenses. The bill applies to all health insurance policies delivered, issued, renewed, or amended in Florida on or after January 1, 2027, and includes various types of health insurers and organizations.

Under this new section, health insurance policies are prohibited from imposing cost-sharing requirements that exceed $35 for a 30-day supply of insulin and $100 for a 30-day supply of diabetes supplies, which encompass items such as blood-glucose test strips and insulin syringes. This legislation aims to alleviate the financial burden on individuals managing diabetes by capping their out-of-pocket expenses for essential medications and supplies. The act is set to take effect on July 1, 2026.